SCHEMBL7247246

SCHEMBL7247246

CCCN(C)Cc1ccc[c]c1CCC(C)C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.32
CHRM2 P08172 1/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7244185 0.89 CHRM2 (0.39) SIGMAR1CHRM2
SCHEMBL5110997 0.82 BCHE (0.36)
SCHEMBL7246974 0.81 HTR2A (0.33)
SCHEMBL5096624 0.81 TSHR (0.35) ALDH1A1
SCHEMBL5110776 0.81 BCHE (0.38) SIGMAR1
SCHEMBL5104015 0.80 BCHE (0.38)
SCHEMBL7252417 0.80 TSHR (0.36) SIGMAR1
SCHEMBL7245388 0.78 BCHE (0.31)
SCHEMBL7246139 0.78 CRHR1 (0.34) ALDH1A1
SCHEMBL677325 0.78 SLC6A2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627624-B1 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome, NEUROGEN CORPORATION 2003-09-30 US disclosed